Skip to main content

Table 1 Baseline characteristics according to the number of vascular beds with recognized atherosclerosis

From: Polyvascular atherosclerosis and renal dysfunction increase the odds of cognitive impairment in vascular disease: findings of the LipidCardio study

Total

n = 829

No atherosclerosis

n = 143 (17.3)

Monovascular disease

n = 589 (71.1)

Polyvascular disease

n = 97 (11.7)

Missings

Age, years

65.8 ± 13.3

72.3 ± 10.0

74.7 ± 9.1

0

Age groups

0

 < 60 years (n = 128)

49 (38.0)

73 (56.6)

7 (5.4)

 60–69 years (n = 201)

30 (14.9)

150 (74.6)

21 (10.5)

 70–79 years (n = 309)

42 (13.6)

225 (72.8)

42 (13.6)

 ≥ 80 years (n = 190)

22 (11.6)

141 (74.2)

27 (14.2)

Sex, male

62 (43.4)

440 (74.7)

76 (78.4)

0

MMSE (mean)

27.9 ± 2.5

27.0 ± 2.9

26.2 ± 2.7

0

MMSE (median)

29 (27–29)

28 (26–29)

27 (25–28)

0

MMSE < 26

15 (10.5)

130 (22.1)

34 (35.1)

0

APO e4 carrier

36 (27.1)

126 (23.1)

30 (34.5)

63

Diabetes mellitus Type 2

25 (17.5)

163 (27.7)

43 (44.3)

0

Hypertension

97 (67.8)

494 (83.9)

78 (80.4)

0

CKD (eGFR < 60 ml/min/1.732)

27 (20.0)

169 (29.5)

43 (45.3)

26

Smoking

28 (19.7)

96 (16.4)

28 (28.9)

4

BMI > 25 kg/m2

55 (38.7)

248 (42.5)

43 (44.3)

6

BMI > 30 kg/m2

38 (26.8)

158 (27.1)

21 (21.7)

6

  1. Data are presented as mean ± standard deviation, numbers(proportions), or median(25th-75th percentile)
  2. BMI body mass index, CKD chronic kidney disease, eGFR estimated glomerular filtration rate, MMSE Mini-Mental State Examination;